Transaction DateRecipientSharesTypePriceValue
8th December 2020Bobbi Jo Brockmann4,742Grant/award etc.$3.15$14,937.30
12th March 2020David Cunningham2,000Open or private purchase$4.00$8,000.00
11th March 2020David Scott Tomsche4,600Open or private purchase$4.28$19,688.00
27th February 2020David Scott Tomsche5,130Open or private purchase$4.98$25,547.40
9th December 2019Bobbi Jo Brockmann1,200Grant/award etc.$3.99$4,788.00
9th December 2019Bobbi Jo Brockmann1,524Grant/award etc.$3.65$5,562.60
11th March 2019Paul R Wainman4,269Grant/award etc.$4.80$20,491.20
Immu Cell Corporation
Immu Cell Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.

ImmuCell Corp. was founded in 1982 and is headquartered in Portland, ME. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment.

Ticker: ICCC
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 811641
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags